Riskpilot← Back to searchSign inGet full accessEMED AS
ASActiveOrg 919971800Sørumsvegen 28, 2022 GjerdrumOther human health activities n.e.c. · NACE 8699Est. 20170 employees
Revenue 2024
NOK 0
EBITDA margin
—
+15% vs 2023
Equity ratio
68.9%
Financial strength
Net profit 2024
NOK -18K
+15% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -18K | +15% |
| Net profit | NOK -18K | +15% |
| Total assets | NOK 68K | -21% |
| Equity | NOK 47K | -28% |
| Employees | 0 | — |
Legal name
EMED AS
Org number
919971800
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
27. november 2017
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Levere helsetjenester, utvikling, drift og salg av medisinteknologiske løsninger og konsulenttjenester innen helse it og annet som naturlig faller sammen med dette.
Address
Sørumsvegen 28, 2022 Gjerdrum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 72 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 65 | −16 | −15 | −22 | −18 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 65 | −16 | −15 | −22 | −18 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 65 | −16 | −15 | −22 | −18 |
| Tax | −0 | 14 | 11 | −0 | −0 |
| Net profit | 65 | −30 | −25 | −22 | −18 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 138 | 115 | 107 | 86 | 68 |
| Equity | 143 | 112 | 87 | 65 | 47 |
| Long-term debt | 5 | 5 | 5 | 5 | 5 |
| Short-term debt | −10 | −2 | 15 | 16 | 16 |
| Total debt | −5 | 3 | 20 | 21 | 21 |
EBITDA margin
-1848300.0%
This company
15.8%
Market median
-11698201% vs market
20202024
Equity ratio
68.9%
This company
38.2%
Market median
+80% vs market
20202024
Return on equity
-39.7%
This company
18.4%
Market median
-316% vs market
20202024
Net profit margin
-1848300.0%
This company
8.1%
Market median
-22818619% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TS Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Sagen | Chief Executive Officer | 0 companies |
| Anne Stokker Sagen | Board of Directors | 0 companies |